Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
filgrastim (neupogen) (2 trials)
sargramostim (leukine) (1 trial)
carboplatin (paraplatin) (1 trial)
cisplatin (platinol) (1 trial)
cyclophosphamide (cytoxan) (3 trials)
docetaxel (taxotere) (1 trial)
doxorubicin (Doxil) (1 trial)
epirubicin (ellence) (2 trials)
estradiol (progynon depot) (1 trial)
etoposide (vepesid) (1 trial)
exemestane (aromasin) (1 trial)
fluorouracil (efudex) (1 trial)
goserelin (zoladex) (2 trials)
letrozole (femara) (1 trial)
pravastatin (pravachol) (1 trial)
tamoxifen (nolvadex) (1 trial)
Breast Neoplasms (Phase 4)
Hot Flashes (Phase 3)
Infertility (Phase 3)
Lung Neoplasms (Phase 3)
Neutropenia (Phase 4)
Osteoporosis (Phase 3)
Prostatic Neoplasms (Phase 3)
Small Cell Lung Carcinoma (Phase 3)
Trials (7 total)
Trial APIs (16 total)
